ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SAF Safran SA

208.60
1.10 (0.53%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Safran SA EU:SAF Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.10 0.53% 208.60 208.10 210.00 211.50 203.10 210.00 680,117 16:40:00

Smiths Group 1st Half Pretax Profit More Than Doubles

24/03/2017 8:28am

Dow Jones News


Safran (EU:SAF)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Safran Charts.

By Olga Cotaga

 

LONDON--Smiths Group PLC (SMIN.LN) on Friday said its pretax profit more than doubled in the first half thanks to some robust sales and profit from a disposal.

Strong sales at its Smiths detection unit, which makes detection and screening technology, offset a decline in sales in its medical and John Crane businesses, which makes products for the energy industry.

The manufacturer of control systems and instruments for industrial applications made a pretax profit of 346 million pounds ($432.4 million) in the six months ended Jan. 31, more than the GBP168 million made in the corresponding period a year earlier. Revenue also rose to GBP1.62 billion from GBP1.37 billion.

Commenting on the planned acquisition of Morpho Detection from France's Safran SA, Chief Executive Andy Reynolds said: "Morpho Detection makes compelling sense and will increase our exposure to a growing market," adding the company is in the final stages to get all the approvals for the acquisition.

On the company's outlook, the CEO said the company expects some improvement in Smiths Medical's revenue performance in the second half but John Crane's "first-fit end markets" are expected to remain tough.

Overall, he expects the full-year outlook to remain unchanged. The board raised the interim dividend by 2.3% to 13.55 pence a share.

Shares closed Thursday at 1,556 pence.

Write to Olga Cotaga at Olga.Cotaga@wsj.com

 

(END) Dow Jones Newswires

March 24, 2017 04:13 ET (08:13 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Safran Chart

1 Year Safran Chart

1 Month Safran Chart

1 Month Safran Chart

Your Recent History

Delayed Upgrade Clock